Malaria Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel

Description

List of Tables

The malaria treatment market is expected to grow from US$ 3.296 billion in 2022 to US$ 24.487 billion by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ~77% across the world; in African countries, P. falciparum accounts for ~96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ~2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020. Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy that aims to eradicate the disease by 2024.

In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023 with an aim to reach millions of people through malaria control interventions and thereby scale up prevention activities in Africa.

Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into generic drugs, originators, vaccines, and others. vaccines segment held the largest market share in 2022. Vaccines provide active acquired immunity against particular infectious disease. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and increasing pipeline of vaccine candidates.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2022; however, the parenteral segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2022; however, the online pharmacies segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

A few of the major primary and secondary sources referred to while preparing the report on the malaria treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00018229

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Malaria Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis - Malaria Treatment

5. Malaria Treatment Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Prevalence of Malaria
- 5.1.2 Rising Initiatives to Raise Awareness about Malaria
5.2 Market Restraints
- 5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
- 5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
- 5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis

6. Malaria Treatment Market - Global Market Analysis

6.1 Malaria Treatment Market Revenue (US$ million), 2022 - 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Vaccines
- 7.3.1 Overview
- 7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Generic Drugs
- 7.4.1 Overview
- 7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Originators
- 7.5.1 Overview
- 7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

8.1 Overview
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Oral
- 8.3.1 Overview
- 8.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Parenteral
- 8.4.1 Overview
- 8.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

9.1 Overview
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Direct Tender
- 9.3.1 Overview
- 9.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Hospital Pharmacies
- 9.4.1 Overview
- 9.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Retail Pharmacies
- 9.5.1 Overview
- 9.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Online Pharmacies
- 9.6.1 Overview
- 9.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others : Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Malaria Treatment Market - Geographical Analysis

10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
- 10.1.1 Overview
- 10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.2.1 North America: Malaria Treatment Market, by Treatment
  - 10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
  - 10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
    - 10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
    - 10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
  - 10.1.2.4 North America: Malaria Treatment Market, by Country
  - 10.1.2.5 US
  - 10.1.2.6 Overview
    - 10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.6.2 US: Malaria Treatment Market, by Treatment
    - 10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
    - 10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
    - 10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
  - 10.1.2.7 Canada
  - 10.1.2.8 Overview
    - 10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
    - 10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
    - 10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
    - 10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
  - 10.1.2.9 Mexico
  - 10.1.2.10 Overview
    - 10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
    - 10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
    - 10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
    - 10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
- 10.2.1 Overview
- 10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.2.2.1 Europe: Malaria Treatment Market, by Treatment
  - 10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
  - 10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.4 Europe: Malaria Treatment Market, by Countries
  - 10.2.2.5 France
  - 10.2.2.6 Overview
    - 10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.6.2 France: Malaria Treatment Market, by Treatment
    - 10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.7 UK
  - 10.2.2.8 Overview
    - 10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
    - 10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.9 Italy
  - 10.2.2.10 Overview
    - 10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
    - 10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.11 Germany
  - 10.2.2.12 Overview
    - 10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
    - 10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.13 Spain
  - 10.2.2.14 Overview
    - 10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
    - 10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
  - 10.2.2.15 Rest of Europe
  - 10.2.2.16 Overview
    - 10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
    - 10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
    - 10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
    - 10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
- 10.3.1 Overview
- 10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
  - 10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
  - 10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
  - 10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
  - 10.3.2.5 Japan
  - 10.3.2.6 Overview
    - 10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
    - 10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
  - 10.3.2.7 India
  - 10.3.2.8 Overview
    - 10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.8.2 India: Malaria Treatment Market, by Treatment
    - 10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
  - 10.3.2.9 South Korea
  - 10.3.2.10 Overview
    - 10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
    - 10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
  - 10.3.2.11 Australia
  - 10.3.2.12 Overview
    - 10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
    - 10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
  - 10.3.2.13 Rest of Asia Pacific
  - 10.3.2.14 Overview
    - 10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
    - 10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
    - 10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
    - 10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
- 10.4.1 Overview
- 10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
  - 10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
  - 10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
  - 10.4.2.5 Saudi Arabia
  - 10.4.2.6 Overview
    - 10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
    - 10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.7 UAE
  - 10.4.2.8 Overview
    - 10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
    - 10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.9 South Africa
  - 10.4.2.10 Overview
    - 10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
    - 10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.11 Kenya
  - 10.4.2.12 Overview
    - 10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
    - 10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.13 Tanzania
  - 10.4.2.14 Overview
    - 10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
    - 10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.15 Rwanda
  - 10.4.2.16 Overview
    - 10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
    - 10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.17 Nigeria
  - 10.4.2.18 Overview
    - 10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
    - 10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.19 Ghana
  - 10.4.2.20 Overview
    - 10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
    - 10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.21 Uganda
  - 10.4.2.22 Overview
    - 10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
    - 10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.23 Angola
  - 10.4.2.24 Overview
    - 10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
    - 10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.25 Cameroon
  - 10.4.2.26 Overview
    - 10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
    - 10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.27 Senegal
  - 10.4.2.28 Overview
    - 10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
    - 10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.29 Zambia
  - 10.4.2.30 Overview
    - 10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
    - 10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
  - 10.4.2.31 Rest of Middle East & Africa
  - 10.4.2.32 Overview
    - 10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
    - 10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
    - 10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
    - 10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
- 10.5.1 Overview
- 10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
  - 10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
  - 10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
    - 10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
    - 10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
  - 10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
  - 10.5.2.5 Brazil
  - 10.5.2.6 Overview
    - 10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
    - 10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
    - 10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
    - 10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
  - 10.5.2.7 Argentina
  - 10.5.2.8 Overview
  - 10.5.2.9 Rest of South & Central America
  - 10.5.2.10 Overview
    - 10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
    - 10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
    - 10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
    - 10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
    - 10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies

11. Malaria Treatment Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Malaria Treatment Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Cipla Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sun Pharmaceutical Industries Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sanofi SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GSK Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Novartis AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Service
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 AdvaCare Pharma USA LLC
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 VLP Therapeutics LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Lupin Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

14. Appendix